Kwality Pharmaceuticals Ltd
KPLKwality Pharmaceuticals Ltd
KPL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹375 cr, stock is ranked 1,631
High RiskStock is 4.27x as volatile as Nifty
385.856.38% (+23.15)
385.856.38% (+23.15)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 25.81 | 1.89 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 40.65 | 4.77 | 0.76% |
Forecast & Ratings
Detailed Forecast—
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Kwality Pharmaceuticals Limited manufactures and exports pharmaceutical formulations for human and veterinary use.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
PE Ratio
32.81
1Y Return
20.85%
Buy Reco %
91.43
Cipla Ltd
PE Ratio
34.18
1Y Return
4.60%
Buy Reco %
68.57
Dr Reddy's Laboratories Ltd
PE Ratio
20.63
1Y Return
23.58%
Buy Reco %
48.65
Mankind Pharma Ltd
PE Ratio
56.10
1Y Return
0.00%
Buy Reco %
45.45
Torrent Pharmaceuticals Ltd
PE Ratio
52.43
1Y Return
19.09%
Buy Reco %
67.86
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 52.80 | 74.53 | 99.53 | 138.29 | 166.90 | 142.96 | 263.60 | 459.70 | 253.97 | 251.59 | ||||||||||
Raw Materials | 37.60 | 57.48 | 72.19 | 104.00 | 114.19 | 92.59 | 165.50 | 203.11 | 113.27 | 208.88 | ||||||||||
| Power & Fuel Cost | 1.80 | 2.31 | 2.81 | 2.76 | 3.71 | 4.20 | 6.13 | 11.07 | 12.98 | |||||||||||
| Employee Cost | 1.60 | 2.16 | 3.60 | 4.89 | 7.74 | 10.92 | 14.70 | 18.80 | 28.16 | |||||||||||
| Selling & Administrative Expenses | 4.66 | 5.35 | 8.91 | 11.07 | 13.71 | 19.59 | 41.70 | 48.74 | 32.64 | |||||||||||
| Operating & Other expenses | 3.45 | 1.85 | 1.91 | 3.10 | 11.22 | -2.22 | 5.12 | 2.80 | 19.79 | |||||||||||
EBITDA | 3.69 | 5.38 | 10.11 | 12.47 | 16.33 | 17.88 | 30.45 | 175.18 | 47.13 | 42.71 | ||||||||||
| Depreciation/Amortization | 1.30 | 1.69 | 2.51 | 2.98 | 3.12 | 4.43 | 6.49 | 10.69 | 14.96 | 16.61 | ||||||||||
| PBIT | 2.39 | 3.69 | 7.60 | 9.49 | 13.21 | 13.45 | 23.96 | 164.49 | 32.17 | 26.10 | ||||||||||
| Interest & Other Items | 1.04 | 1.22 | 1.95 | 2.21 | 2.29 | 2.52 | 2.68 | 2.92 | 6.61 | 6.99 | ||||||||||
| PBT | 1.35 | 2.47 | 5.65 | 7.28 | 10.92 | 10.93 | 21.28 | 161.57 | 25.56 | 19.11 | ||||||||||
| Taxes & Other Items | 0.44 | 0.92 | 2.28 | 2.75 | 3.35 | 2.60 | 6.12 | 41.57 | 6.21 | 4.55 | ||||||||||
| Net Income | 0.91 | 1.55 | 3.37 | 4.53 | 7.57 | 8.33 | 15.16 | 120.00 | 19.35 | 14.56 | ||||||||||
| EPS | 0.48 | 0.77 | 2.22 | 4.37 | 7.30 | 8.03 | 14.61 | 115.65 | 18.65 | 14.03 | ||||||||||
| DPS | 0.00 | 0.00 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
FY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFPeers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Kwality Pharmaceuticals Ltd | 19.42 | 1.89 | — |
| Sun Pharmaceutical Industries Ltd | 32.81 | 4.69 | 0.99% |
| Cipla Ltd | 34.18 | 4.04 | 0.72% |
| Dr Reddy's Laboratories Ltd | 20.63 | 3.99 | 0.72% |
Price Comparison
Compare KPL with any stock or ETFCompare KPL with any stock or ETF
KPL
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 2.66%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
KPL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJan 5, 2017
Interim
Interim | Div/Share: ₹0.60
Dividend/Share
₹0.60
Ex DateEx Date
Jan 5, 2017
News & Opinions
Articles & Videos
Hmm, looks like data is unavailable here. Please come back after some time.
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 12.93%, vs industry avg of 8.45%
Increasing Market Share
Over the last 5 years, market share increased from 0.07% to 0.08%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 33.7%, vs industry avg of 9.81%